0
March 4, 1992, Vol 267, No. 9 >
ARTICLE | March 4, 1992

The Concepts of Stress and Stress System Disorders: Title and subTitle BreakOverview of Physical and Behavioral Homeostasis FREE

George P. Chrousos, MD; Philip W. Gold, MD
[+] Author Affiliations

Reprint requests to National Institutes of Health, Bldg 10, Room 10N262, Bethesda, MD 20892 (Dr Chrousos).


JAMA. 1992;267(9):1244-1252. doi:10.1001/jama.1992.03480090092034
Text Size: A A A
Published online
Article
References

Objective.  —This article defines stress and related concepts and reviews their historical development. The notion of a stress system as the effector of the stress syndrome is suggested, and its physiologic and pathophysiologic manifestations are described. A new perspective on human disease states associated with dysregulation of the stress system is provided.

Data Sources.  —Published original articles from human and animal studies and selected reviews. Literature was surveyed utilizing MEDLINE and the Index Medicus.

Study Selection.  —Original articles from the basic science and human literature consisted entirely of controlled studies based on verified methodologies and, with the exception of the most recent studies, replicated by more than one laboratory. Many of the basic science and clinical studies had been conducted in our own laboratories and clinical research units. Reviews cited were written by acknowledged leaders in the fields of neurobiology, endocrinology, and behavior.

Data Extraction.  —Independent extraction and cross-referencing by the authors.

Data Synthesis.  —Stress and related concepts can be traced as far back as written science and medicine. The stress system coordinates the generalized stress response, which takes place when a stressor of any kind exceeds a threshold. The main components of the stress system are the corticotropin-releasing hormone and locus ceruleus-norepinephrine/autonomic systems and their peripheral effectors, the pituitary-adrenal axis, and the limbs of the autonomic system. Activation of the stress system leads to behavioral and peripheral changes that improve the ability of the organism to adjust homeostasis and increase its chances for survival. There has been an exponential increase in knowledge regarding the interactions among the components of the stress system and between the stress system and other brain elements involved in the regulation of emotion, cognitive function, and behavior, as well as with the axes responsible for reproduction, growth, and immunity. This new knowledge has allowed association of stress system dysfunction, characterized by sustained hyperactivity and/or hypoactivity, to various pathophysiologic states that cut across the traditional boundaries of medical disciplines. These include a range of psychiatric, endocrine, and inflammatory disorders and/or susceptibility to such disorders.

Conclusions.  —We hope that knowledge from apparently disparate fields of science and medicine integrated into a working theoretical framework will allow generation and testing of new hypotheses on the pathophysiology and diagnosis of, and therapy for, a variety of human illnesses reflecting systematic alterations in the principal effectors of the generalized stress response. We predict that pharmacologic agents capable of altering the central apparatus that governs the stress response will be useful in the treatment of many of these illnesses.(JAMA. 1992;267:1244-1252)

REFERENCES

1 +
Chrousos GP, Loriaux DL, Gold PW, eds. Mechanisms of Physical and Emotional Stress . New York, NY: Plenum Press; 1988;. Advances in Experimental Medicine and Biology, vol 245.
2 +
Taylor HO. Greek Biology and Medicine . Boston, Mass: Marshall Jones Co; 1922;.
3 +
Singer C. A Short History of Science . Oxford, England: Oxford University Press; 1941;.
4 +
Medvei VC. A History of Endocrinology . Boston, Mass: MTP Press Ltd; 1982;.
5 +
Selye H. Stress . Montreal, Quebec: Acta Medical Publisher Inc; 1950;.
6 +
Witzmann RF. Steroids: Keys to Life . New York, NY: Van Nostrand Reinhold Co; 1981;.
7 +
Gold PW, Goodwin F, Chrousos GP.  Clinical and biochemical manifestations of depression: relationship to the neurobiology of stress, part 1. N Engl J Med . 1988;;319:348-353.
8 +
Gold PW, Goodwin FK, Chrousos GP.  Clinical and biochemical manifestations of depression: relationship to the neurobiology of stress, part 2. N Engl J Med . 1988;;319:413-420.
9 +
Cummings S, Elder R, Ellis J, Lindall A.  Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci . 1983;;3:1355-1368.
10 +
Swanson LW, Sawchenko PE, Rivier J, Vale WW.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology . 1983;;36:165-186.
11 +
Swanson LW, Sawchenko PE.  Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Ann Rev Neurosci . 1983;;6:269-324.
12 +
DeSouza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar M.  Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci . 1985;;5:3189-3203.
13 +
Dunn AJ, Berridge CW.  Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev . 1990;;15:71-100.
14 +
Rock JP, Oldfield EH, Schulte HM, et al.  Corticotropin releasing factor administered into the ventricular CSF stimulates the pituitary-adrenal axis. Brain Res . 1984;;323:365-368.
15 +
Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W.  Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology . 1982;;111:928-931.
16 +
Brown MR.  Neuropeptide-mediated regulation of the neuroendocrine and autonomic responses to stress.  In: McCubbin J, Kaufman P, Nemeroff C, eds. Stress, Neuropeptides and Systemic Disease . New York, NY: Academic Press Inc; 1991;:73-93.
17 +
Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W.  Corticotropin releasing factor produces behavioral activation in rats. Nature . 1982;;297:331-333.
18 +
Britton DR, Koob GF, Rivier J, Vale W.  Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci . 1982;;31:363-367.
19 +
Sirinathsinghji DJS, Rees LH, Rivier J, Vale W.  Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature . 1983;;305:232-235.
20 +
Rivier C, Vale W.  Influence of corticotropin-releasing factor on reproductive functions in the rat. Endocrinology . 1984;;114:914-921.
21 +
Swerdlow NR, Geyer MA, Vale WW, Koob GF.  Corticotropin-releasing factor potentiates acoustic startle in rats; blockade by chlordiazepoxide. Psychopharmacology (Berl) . 1986;;88:147-152.
22 +
Cole B, Koob GF.  Corticotropin-releasing factor, stress, and animal behavior.  In: McCubbin JA, Kaufman PG, Nemeroff CB, eds. Stress, Neuropeptides and Systemic Disease . New York, NY: Academic Press Inc; 1991;:119-148.
23 +
Nauta WJH, Feirtag M. Fundamental Neuroanatomy . New York, NY: WH Freeman & Co; 1986;.
24 +
Valentino RJ, Foote SL, Aston-Jones G.  Corticotropin-releasing hormone activates noradrenergic neurons of the locus coeruleus. Brain Res . 1983;;270:363-367.
25 +
Valentino RJ, Wehby RG.  Corticotropin releasing factor: evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress. Neuroendocrinology . 1988;;48:674-677.
26 +
Valentino RJ, Foote SL.  Corticotropin releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus ceruleus neurons in unanesthetized rats. J Neurosci . 1988;;8:1016-1025.
27 +
Calogero AE, Gallucci WT, Chrousos GP, Gold PW.  Effect of the catecholamines upon rat hypothalamic corticotropin releasing hormone secretion in vitro: clinical implications. J Clin Invest . 1988;;82:839-846.
28 +
Cunningham ET Jr, Sawchenko PE.  Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neural . 1988;;274:60-76.
29 +
Cunningham ET Jr, Bohn MC, Sawchenko PE.  The organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neural . 1990;;292:651-667.
30 +
Saper CB, Loewy AD, Swanson LW, Cowan WM.  Direct hypothalamoautonomic connections. Brain Res . 1979;;117:305-312.
31 +
Saper CB, Loewy AD.  Efferent connections of the parabrachial nucleus in the rat. Brain Res . 1980;;197:291-317.
32 +
Calogero AE, Bernardini R, Margioris AN, et al.  Serotonin stimulates rat hypothalamic corticotropin releasing hormone secretion in vitro. Peptides . 1989;;10:189-210.
33 +
Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP.  Mechanisms of serotonin agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology . 1990;;126:1888-1894.
34 +
Liposits ZS, Phelix C, Paull WK.  Synaptic interaction of serotonergic axons and corticotropin releasing factor synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry . 1987;;86:541-549.
35 +
Bagdy G, Calogero AE, Murphy D, Szemeredi K.  Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology . 1989;;165:2664-2669.
36 +
Calogero AE, Bernardini R, Gallucci WT, Saoutis C, Gold PW, Chrousos GP.  Cholinergic stimulation of rat hypothalamic corticotropin releasing hormone in vitro. Neuroendocrinology . 1988;;47:303-308.
37 +
Calogero A, Kamilaris T, Gomez MT, et al.  The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone mechanism. Endocrinology . 1989;;125:2445-2453.
38 +
Foote SL, Bloom FE, Aston-Jones G.  Nucleus locus ceruleus: new evidence for anatomical and physiological specificity. Physiol Rev . 1983;;63:844-914.
39 +
Aston-Jones G, Foote SL, Bloom FE.  Anatomy and physiology of locus coeruleus neurons: functional implications.  In: Ziegler MG, Lake CR, eds. Norepinephrine . Baltimore, Md: Williams & Wilkins; 1984;:92-116.
40 +
Aghajanian GK.  Mescaline and LSD facilitate the activation of the locus coeruleus neurons by peripheral stimuli. Brain Res . 1980;;186:492-498.
41 +
Guynet PG, Aghajanian GK.  Acetylcholine, substance P and met-enkephalin in the locus coeruleus: pharmacological evidence for independent sites of action. Eur J Pharmacol . 1979;;53:319-328.
42 +
Calogero AE, Gallucci WT, Chrousos GP, Gold PW.  Interaction between gabaergic neurotransmission and rat hypothalamic corticotropin releasing hormone secretion in vitro. Brain Res . 1988;;463:28-36.
43 +
Kalogeras KT, Calogero AE, Kuribayashi T, et al.  In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic pituitary-adrenal function: pharmacologic and clinical implications. J Clin Endocrinol Metab . 1990;;70:1462-1471.
44 +
Bird SJ, Kuhar MJ.  Iontophoretic application of opiates to the locus ceruleus. Brain Res . 1977;;122:523-533.
45 +
Pepper CM, Henderson G.  Opiates and opioid peptides hyperpolarize locus coeruleus neurons in vitro. Science . 1980;;209:394-396.
46 +
Calogero A, Gallucci WT, Gold PW, Chrousos GP.  Multiple regulatory feedback loops on hypothalamic corticotropin releasing hormone secretion. J Clin Invest . 1988;;82:767-774.
47 +
Yajima F, Suda T, Tomori N, et al.  Effect of opioid peptides on immunoreactive corticotropinreleasing factor release from the rat hypothalamus in vitro. Life Sci . 1986;;39:181-186.
48 +
Plotsky PM.  Opioid inhibition of immunoreactive corticotropin releasing factor secretion into the hypophysial-portal circulation of rats. Regul Pept . 1986;;16:235-242.
49 +
Szemeredi K, Bagdy G, Stull R, Calogero AE, Kopin II, Goldstein DS.  Sympathoadrenomedullary inhibition by chronic glucocorticoid treatment in conscious rats. Endocrinology . 1988;;123:2585-2590.
50 +
Nikolarakis KE, Almeida OFX, Herz A.  Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor. Brain Res . 1986;;399:152-155.
51 +
Burns G, Almeida OFX, Passarelli F, Herz A.  A two step mechanism by which corticotropin releasing hormone releases hypothalamic β-endorphin: the role of vasopressin and G-proteins. Endocrinology . 1989;;125:1365-1372.
52 +
Silverman A, Hou-Yu A, Chen WP.  Corticotropin releasing factor synapses within the paraventricular nucleus of the hypothalamus. Neuroendocrinology . 1989;;49:291-299.
53 +
Aghajanian GK, Cedarbaum MJ, Wang RY.  Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res . 1977;;136:570-577.
54 +
Aghajanian GK, VanderMaelen CP.  α2-Adrenoreceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science . 1982;;215:1394-1396.
55 +
Lamberts SWJ, Verleun T, Oosterom R, deJong F, Hackeny WHL.  Corticotropin releasing factor and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab . 1984;;58:298-303.
56 +
Rittmaster RS, Cutler GB Jr, Brandon D, Gold PW, Loriaux DL, Chrousos GP.  The effects of endogenous vasopressin on ACTH and cortisol secretion in man. J Clin Endocrinol Metab . 1987;;64:371-376.
57 +
Olper HR, Baltzer V.  Vasopressin activates noradrenergic neurons in the rat locus coeruleus: a microiontophoretic investigation. Eur J Pharmacol . 1981;;73:377-378.
58 +
Elkabir DR, Wyatt ME, Vellucci SV, Herbert J.  The effects of separate or combined infusions of corticotropin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. Regul Peptides . 1990;;28:199-214.
59 +
Roth KA, Weber E, Barchas JD, Chang D, Chang JK.  Immunoreactive dynorphin-(1-8) and corticotropin-releasing factor in subpopulation of hypothalamic neurons. Science . 1983;;219:189-191.
60 +
Watson SJ, Akil H, Fischli W, et al.  Dynorphin and vasopressin: common localization in magnocellular neurons. Science . 1982;;216:85-87.
61 +
Millan MH, Millan MJ, Przewlocki R.  Lesions of hypothalamic arcuate nucleus modify discrete brain and pituitary pools of dynorphin in addition to β-endorphin in the rat. Neurosci Lett . 1984;;48:149-154.
62 +
Overton JM, Fisher LA.  Modulation of central nervous system actions of corticotropin-releasing factor by dynorphin-related peptides. Brain Res . 1989;;488:233-240.
63 +
Tassin JP, Lavielle S, Herve D, et al.  Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles. Neuroscience . 1979;;4:1569-1582.
64 +
Roth RH, Tam SY, Lda Y, Yang JS, Deutch AY.  Stress and the mesocorticolimbic dopamine systems. Ann N Y Acad Sci . 1988;;537:138-147.
65 +
Deutch AY, Clark WA, Roth RH.  Prefrontal cortical dopamine depletion enhances the responsiveness of the mesolimbic dopamine neurons to stress. Brain Res . 1990;;521:311-315.
66 +
Deutch AY, Goldstein M, Roth RH.  Activation of the locus ceruleus by selective stimulation of the ventral tegmental area. Brain Res . 1986;;363:307-314.
67 +
Imperato A, Puglisi-Allegra S, Casolini P, Angelucci L.  Changes in brain dopamine and acetycholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res . 1991;;538:111-117.
68 +
Gray TS.  Amygdala: role in autonomic and neuroendocrine responses to stress.  In: McCubbin JA, Kaufman PG, Nemeroff CB, eds. Stress, Neuropeptides and Systemic Disease . New York, NY: Academic Press Inc; 1991;:37-53.
69 +
Gray TS.  Autonomic neuropeptide connections of the amygdala.  In: Tache Y, Morley JE, Brown MR, eds. Neuropeptides and Stress . New York, NY: Springer-Verlag NY Inc; 1989;:92-106.
70 +
Loughlin SE, Foote SL, Grzanna R.  Efferent projections of nucleus locus coeruleus: morphological subpopulations have different efferent targets. Neuroscience . 1986;;18:307-319.
71 +
Stock G, Rupprecht U, Strumpf H, Schlor H.  Cardiovascular changes during arousal elicited by stimulation of amygdala, hypothalamus and locus ceruleus. J Auton Nerv Syst . 1981;;3:503-510.
72 +
Zhang TX, Harper KM, Ni H.  Cryogenic blockade of the central nucleus of the amygdala attenuates aversively conditioned blood pressure and respiratory responses. Brain Res . 1986;;386:136-145.
73 +
Sakanaka M, Shibasaki T, Lederis K.  Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in rat amygdaloid complex. Brain Res . 1986;;382:213-238.
74 +
Wallace DM, Magnuson DJ, Gray TS.  The amygdala-brainstem pathway: selective innervation of dopaminergic, noradrenergic and adrenergic cells in the rat. Neurosci Lett . 1989;;97:252-258.
75 +
Magnuson DJ, Gray TS.  Amygdala directly innervates parvocellular paraventricular hypothalamic CRF, vasopressin and oxytocin containing cells. Soc Neurosci . 1988;;14:1288.
76 +
Smelik PG.  Adaptation and brain function. Prog Brain Res . 1987;;72:3-9.
77 +
McEwen BS, Brinton RE.  Neuroendocrine aspects of adaptation. Prog Brain Res . 1987;;72:11-26.
78 +
Herman JP, Schafer MK-H, Young EA, et al.  Evidence of hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci . 1989;;9:3072-3082.
79 +
Kachaturian H, Lewis ME, Tsou K, Watson SJ.  β-Endorphin, αMSH, ACTH, and related peptides.  In: Bjorkland A, Hokfelt T, eds. Handbook of Chemical Neuroanatomy . Amsterdam, the Netherlands: Elsevier Science Publishers; 1985;;4:216-264.
80 +
Palkovits M, Eskay RL.  Distribution and possible origin of β-endorphin and ACTH in discrete brainstem nuclei of rats. Neuropeptides . 1987;;9:123-137.
81 +
Rabin D, Gold PW, Margioris A, Chrousos GP.  Stress and reproduction: interactions between the stress and reproductive axis.  In: Chrousos GP, Loriaux DL, Gold PW, eds. Mechanisms of Physical and Emotional Stress . New York, NY: Plenum Press; 1988;:377-387.
82 +
Ono N, Lumpkin MD, Samson WK, McDonald JK, McCann SM.  Intrahypothalamic action of corticotropin-releasing factor to inhibit growth hormone and LH release in the rat. Life Sci . 1984;;35:1117-1123.
83 +
Rivier C, Rivier J, Vale W.  Stress-induced inhibition of reproductive function: role of endogenous corticotropin-releasing factor. Science . 1986;;231:607-611.
84 +
MacAdams MR, White RH, Chipps BE.  Reduction in serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med . 1986;;140:648-652.
85 +
Rabin D, Johnson E, Brandon D, Liapi C, Chrousos GP.  Glucocorticoids inhibit estradiol-induced uterine growth: possible role of estrogen receptors. Biol Reprod . 1990;;42:74-80.
86 +
Dieguez C, Page MD, Scanlon MF.  Growth hormone neuroregulation and its alterations in disease states. Clin Endocrinol (Oxf) . 1988;;28:109-143.
87 +
Rivier C, Vale W.  Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology . 1985;;117:2478-2482.
88 +
Unterman TG, Phillips LS.  Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab . 1985;;61:618-626.
89 +
Burguera B, Muruais C, Penalva A, Dieguez C, Casanueva F.  Dual and selective actions of glucocorticoid upon basal and stimulated growth hormone release in man. Neuroendocrinology . 1990;;51:51-58.
90 +
Casanueva FF, Burguera B, Muruais C, Dieguez C.  Acute administration of corticosteroids: a new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab . 1990;;70:234-237.
91 +
Duick DS, Wahner HW.  Thyroid axis in patients with Cushing's syndrome. Arch Intern Med . 1979;;139:767-772.
92 +
Benker G, Raida M, Olbricht T, Wagner R, Reinhardt W, Reinwein D.  TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goitre, and the 'sick euthyroid syndrome.' Clin Endocrinol (Oxf) . 1990;;33:777-786.
93 +
Munck A, Guyre PM.  Glucocorticoid physiology, pharmacology and stress.  In: Chrousos GP, Loriaux DL, Lipsett MB, eds. Steroid Hormone Resistance: Mechanisms and Clinical Aspects . New York, NY: Plenum Press; 1986;:81-96.
94 +
Munck A, Guyre PM, Holbrook NJ.  Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev . 1984;;5:25-44.
95 +
Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W.  Interleukin 1 stimulates the secretion of hypothalamic corticotropin releasing factor. Science . 1987;;238:522-524.
96 +
Naito Y, Fukata J, Tominaga T, et al.  Interleukin 6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely moving rats. Biochem Biophys Res Commun . 1988;;155:1459-1463.
97 +
Bernardini R, Kamilaris TC, Calogero AE, Johnson EO, Gold PW, Chrousos GP.  Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone and adrenocorticotropin secretion in the rat. Endocrinology . 1990;;126:2876-2881.
98 +
Bernardini R, Calogero AE, Ehlich YH, Brucke T, Chrousos GP, Gold PW.  The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology . 1989;;125:1067-1073.
99 +
Bernardini R, Chiarenza A, Calogero AE, Gold PW, Chrousos GP.  Arachidonic acid metabolites modulate rat hypothalamic corticotropin releasing hormone secretion in vitro. Neuroendocrinology . 1989;;50:708-715.
100 +
Gold PW, Loriaux DL, Roy A, et al.  Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: pathophysiologic and diagnostic implications. N Engl J Med . 1986;;314:1329-1335.
101 +
Roy A, Pickar D, Linnoila M, Chrousos GP, Gold PW.  Cerebrospinal fluid corticotropin releasing hormone in depression: relationship to noradrenergic function. Psychiatry Res . 1987;;20:229-237.
102 +
Christiansen NJ, Vestergaard P, Sorenson T, Raphaelson VJ.  Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatr Scand . 1980;;61:178-182.
103 +
Wyatt RJ, Protnoy G, Kupfer DJ, Snyder F, Engelman K.  Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry . 1971;;24:65-70.
104 +
Nemeroff CB, Widerlov E, Poissette G, et al.  Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science . 1984;;226:1342-1344.
105 +
Kling MA, Doran A, Rubinow DR, et al.  CSF levels of CRH, ACTH, and SRIF in Cushing's syndrome, major depression, and normal volunteers: physiological and pathophysiological interrelationships. J Clin Endocrinol Metab . 1991;;72:260-271.
106 +
Gold PW, Gwirtsman H, Avgerinos P, et al.  Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med . 1986;;314:1335-1342.
107 +
Kaye WH, Gwirtsman HE, George DT, et al.  Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocrinol Metab . 1987;;64:203-208.
108 +
Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW.  The CRH stimulation test in patients with panic disorder. Am J Psychiatry . 1986;;143:396-399.
109 +
Gold PW, Pigott TA, Kling MK, Kalogeras K, Chrousos GP.  Basic and clinical studies with corticotropin releasing hormone: implications for a possible role in panic disorder. Psychiatr Clin North Am . 1988;;11:327-334.
110 +
Insel TR, Kalin NH, Guttmacher LB, Cohen RM, Murphy DL.  The dexamethasone suppression test in obsessive-compulsive disorder. Psychiatr Res . 1982;;6:153-160.
111 +
Wand GS, Dobs AS.  Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab . 1991;;72:1290-1295.
112 +
Risher-Flowers D, Adinoff B, Ravitz B, et al.  Circadian rhythms of cortisol during alcohol withdrawal. Adv Alcohol Subst Abuse . 1988;;7:37-41.
113 +
Bardeleben V, Heuser I, Holsboer F.  Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoneuroendocrinology . 1989;;14:441-449.
114 +
Mendelson JH, Teoh SK, Lang V, et al.  Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am J Psychiatry . 1988;;145:1094-1098.
115 +
Mellman TA, Uhde TW.  Withdrawal syndrome with gradual tapering of alprazolam. Am J Psychiatry . 1986;;143:1464-1466.
116 +
Adam K, Oswald I, Shapiro C.  Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol. Psychopharmacology . 1984;;82:389-394.
117 +
Luger A, Deuster P, Kyle SB, et al.  Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise: physiologic adaptations to physical training. N Engl J Med . 1987;;316:1309-1315.
118 +
Malozowski S, Muzzo S, Burrows R, et al.  The hypothalamic-pituitary adrenal axis in infantile malnutrition. Clin Endocrinol . 1990;;32:461-465.
119 +
Kamilaris A, Calogero AE, Johnson EO, Gold PW, Chrousos GP.  Effects of hypothyroidism and hyperthyroidism on the basal activity of the hypothalamic-pituitary-adrenal axis. Clin Res . 1989;;37:360A.
120 +
Rabin D, Schmidt P, Gold PW, Rubinow D, Chrousos GP.  Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. J Clin Endocrinol Metab . 1990;;71:1158-1162.
121 +
Cantwell DP, Sturzenberger S, Burroughs J, Salkin B, Green JK.  Anorexia nervosa: an affective disorder? Arch Gen Psychiatry . 1977;;34:1087-1093.
122 +
Winokur A, March W, Mendels J.  Primary affective disorder in relatives of patients with anorexia nervosa. Am J Psychiatry . 1980;;137:695-698.
123 +
Gold PW, Ballenger JC, Robertson GL, et al.  Vasopressin in affective illness: direct measurement, clinical trials, and response to hypertonic saline.  In: Post RM, Ballenger JC, eds. Neurobiology of Mood Disorders . Baltimore, Md: Williams & Wilkins; 1984;:323-339.
124 +
DeWied D.  The importance of vasopressin in memory. Trends Neurosci . 1984;;7:62-63.
125 +
Yates A, Leehey K, Shisslak CM.  Running—an analogue of anorexia? N Engl J Med . 1983;;308:251-255.
126 +
MacConnie SE, Barkan A, Lampman RM, Schork MA, Beitins IZ.  Decreased hypothalamic gonadotropin-releasing hormone secretion in male marathon runners. N Engl J Med . 1986;;315:411-417.
127 +
Villanueva AL, Schlosser C, Hopper B, Liu JH, Hoffman DI, Rebar RW.  Increased cortisol production in women runners. J Clin Endocrinol Metab . 1986;;63:133-136.
128 +
Piazza PV, Maccari S, Deminiere JM, Le Moal M, Mormede P, Simon H.  Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci U S A . 1991;;88:2088-2092.
129 +
Vanderpool J, Rosenthal N, Chrousos GP, Wher T, Gold PW.  Evidence for hypothalamic CRH deficiency in patients with seasonal affective disorder. J Clin Endocrinol Metab . 1991;;72:1382-1387.
130 +
Demitrack MA, Dale JK, Straus S, et al.  Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab . 1991;;73:1224-1234.
131 +
Kamilaris TC, DeBold RC, Pavlou SN, Island DP, Hoursanidis A, Orth DN.  Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab . 1987;;65:994-999.
132 +
Kopelman PG, Grossman A, Lavender P, Besser GM, Rees LH, Coy D.  The cortisol response to corticotrophin-releasing factor is blunted in obesity. Clin Endocrinol (Oxf) . 1988;;28:15-18.
133 +
Bernasconi S, Petraglia F, Iughetti L, et al.  Impaired β-endorphin response to human corticotropin-releasing hormone in obese children. Acta Endocrinol. (Copenh) . 1988;;119:7-10.
134 +
Bernini GP, Argenio GF, Viraldi MJ, et al.  Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotonergic system. Horm Res . 1989;;31:133-137.
135 +
Mason JW, Giller EL, Kosten TR, Ostroff RB, Podd L.  Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis . 1986;;174:145-149.
136 +
Yehuda R, Southwick SM, Nussbaum F, Wahby V, Giller EL, Mason JW.  Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis . 1990;;178:366-369.
137 +
McFall ME, Murburg MM, Ko GN, Veith RC.  Autonomic responses to stress in Vietnam combat veterans with posttraumatic stress disorder. Biol Psychiatry . 1990;;27:1165-1175.
138 +
Butler RW, Braff DL, Rausch TL, Jenkins MA, Sprock J, Geyer MA.  Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry . 1990;;147:1308-1312.
139 +
Elgerot A.  Psychological and physiological changes during tobacco-abstinence in habitual smokers. J Clin Psychol . 1978;;34:759-764.
140 +
West RJ, Russell MAH, Jarvis MJ, Pizzey T, Kadam B.  Urinary adrenaline concentrations during 10 days of smoking abstinence. Psychopharmacology . 1984;;84:141-142.
141 +
Puddey JB, Vandongen R, Beilin LJ, English D.  Haemodynamic and neuroendocrine consequences of stopping smoking—a controlled study. Clin Exp Pharmacol Physiol . 1984;;11:423-426.
142 +
Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T.  Smoking cessation and severity of weight gain in a national cohort. N Engl J Med . 1991;;324:739-745.
143 +
Sternberg E, Hill JM, Chrousos GP, et al.  Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A . 1989;;86:2374-2378.
144 +
Sternberg EM, Young WS Jr, Bernardini R, et al.  A central nervous defect in the stress response is associated with susceptiblility to streptococcal cell wall arthritis in Lewis rats. Proc Natl Acad Sci U S A . 1989;;86:4771-4775.
145 +
Sternberg EM, Glowa J, Smith M, et al.  Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res . 1992;;570:54-60.
146 +
Gawin GH.  Cocaine addiction: psychology and neurophysiology. Science . 1991;;251:1580-1586.
147 +
Thoman EB, Levine ES, Arnold WJ.  Effects of maternal deprivation and incubation rearing on adrenocortical activity in the adult rat. Dev Psychobiol . 1968;;1:21-23.
148 +
Kagan J, Reznick JS, Snidman N.  Biological bases of childhood shyness. Science . 1988;;240:167-171.
149 +
Kagan J, Reznick JS, Snidman N.  Temperamental influences on reactions to unfamiliarity and challenge.  In: Chrousos GP, Loriaux DL, Gold PW, eds. Mechanisms of Physical and Emotional Stress . New York, NY: Plenum Press; 1988;:319-339.
150 +
Werner EE.  Children of the garden island. Sci Am . (April) 1989;;260:106-111.
151 +
Bouchard TJ Jr, Lykken DT, McGue M, Segal NL, Tellegen A.  Sources of human psychological differences: The Minnesota Study of Twins Reared Apart. Science . 1990;;250:223-250.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

1 +
Chrousos GP, Loriaux DL, Gold PW, eds. Mechanisms of Physical and Emotional Stress . New York, NY: Plenum Press; 1988;. Advances in Experimental Medicine and Biology, vol 245.
2 +
Taylor HO. Greek Biology and Medicine . Boston, Mass: Marshall Jones Co; 1922;.
3 +
Singer C. A Short History of Science . Oxford, England: Oxford University Press; 1941;.
4 +
Medvei VC. A History of Endocrinology . Boston, Mass: MTP Press Ltd; 1982;.
5 +
Selye H. Stress . Montreal, Quebec: Acta Medical Publisher Inc; 1950;.
6 +
Witzmann RF. Steroids: Keys to Life . New York, NY: Van Nostrand Reinhold Co; 1981;.
7 +
Gold PW, Goodwin F, Chrousos GP.  Clinical and biochemical manifestations of depression: relationship to the neurobiology of stress, part 1. N Engl J Med . 1988;;319:348-353.
8 +
Gold PW, Goodwin FK, Chrousos GP.  Clinical and biochemical manifestations of depression: relationship to the neurobiology of stress, part 2. N Engl J Med . 1988;;319:413-420.
9 +
Cummings S, Elder R, Ellis J, Lindall A.  Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci . 1983;;3:1355-1368.
10 +
Swanson LW, Sawchenko PE, Rivier J, Vale WW.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology . 1983;;36:165-186.
11 +
Swanson LW, Sawchenko PE.  Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Ann Rev Neurosci . 1983;;6:269-324.
12 +
DeSouza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar M.  Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci . 1985;;5:3189-3203.
13 +
Dunn AJ, Berridge CW.  Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev . 1990;;15:71-100.
14 +
Rock JP, Oldfield EH, Schulte HM, et al.  Corticotropin releasing factor administered into the ventricular CSF stimulates the pituitary-adrenal axis. Brain Res . 1984;;323:365-368.
15 +
Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W.  Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology . 1982;;111:928-931.
16 +
Brown MR.  Neuropeptide-mediated regulation of the neuroendocrine and autonomic responses to stress.  In: McCubbin J, Kaufman P, Nemeroff C, eds. Stress, Neuropeptides and Systemic Disease . New York, NY: Academic Press Inc; 1991;:73-93.
17 +
Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W.  Corticotropin releasing factor produces behavioral activation in rats. Nature . 1982;;297:331-333.
18 +
Britton DR, Koob GF, Rivier J, Vale W.  Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci . 1982;;31:363-367.
19 +
Sirinathsinghji DJS, Rees LH, Rivier J, Vale W.  Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature . 1983;;305:232-235.
20 +
Rivier C, Vale W.  Influence of corticotropin-releasing factor on reproductive functions in the rat. Endocrinology . 1984;;114:914-921.
21 +
Swerdlow NR, Geyer MA, Vale WW, Koob GF.  Corticotropin-releasing factor potentiates acoustic startle in rats; blockade by chlordiazepoxide. Psychopharmacology (Berl) . 1986;;88:147-152.
22 +
Cole B, Koob GF.  Corticotropin-releasing factor, stress, and animal behavior.  In: McCubbin JA, Kaufman PG, Nemeroff CB, eds. Stress, Neuropeptides and Systemic Disease . New York, NY: Academic Press Inc; 1991;:119-148.
23 +
Nauta WJH, Feirtag M. Fundamental Neuroanatomy . New York, NY: WH Freeman & Co; 1986;.
24 +
Valentino RJ, Foote SL, Aston-Jones G.  Corticotropin-releasing hormone activates noradrenergic neurons of the locus coeruleus. Brain Res . 1983;;270:363-367.
25 +
Valentino RJ, Wehby RG.  Corticotropin releasing factor: evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress. Neuroendocrinology . 1988;;48:674-677.
26 +
Valentino RJ, Foote SL.  Corticotropin releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus ceruleus neurons in unanesthetized rats. J Neurosci . 1988;;8:1016-1025.
27 +
Calogero AE, Gallucci WT, Chrousos GP, Gold PW.  Effect of the catecholamines upon rat hypothalamic corticotropin releasing hormone secretion in vitro: clinical implications. J Clin Invest . 1988;;82:839-846.
28 +
Cunningham ET Jr, Sawchenko PE.  Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neural . 1988;;274:60-76.
29 +
Cunningham ET Jr, Bohn MC, Sawchenko PE.  The organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neural . 1990;;292:651-667.
30 +
Saper CB, Loewy AD, Swanson LW, Cowan WM.  Direct hypothalamoautonomic connections. Brain Res . 1979;;117:305-312.
31 +
Saper CB, Loewy AD.  Efferent connections of the parabrachial nucleus in the rat. Brain Res . 1980;;197:291-317.
32 +
Calogero AE, Bernardini R, Margioris AN, et al.  Serotonin stimulates rat hypothalamic corticotropin releasing hormone secretion in vitro. Peptides . 1989;;10:189-210.
33 +
Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP.  Mechanisms of serotonin agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology . 1990;;126:1888-1894.
34 +
Liposits ZS, Phelix C, Paull WK.  Synaptic interaction of serotonergic axons and corticotropin releasing factor synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry . 1987;;86:541-549.
35 +
Bagdy G, Calogero AE, Murphy D, Szemeredi K.  Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology . 1989;;165:2664-2669.
36 +
Calogero AE, Bernardini R, Gallucci WT, Saoutis C, Gold PW, Chrousos GP.  Cholinergic stimulation of rat hypothalamic corticotropin releasing hormone in vitro. Neuroendocrinology . 1988;;47:303-308.
37 +
Calogero A, Kamilaris T, Gomez MT, et al.  The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone mechanism. Endocrinology . 1989;;125:2445-2453.
38 +
Foote SL, Bloom FE, Aston-Jones G.  Nucleus locus ceruleus: new evidence for anatomical and physiological specificity. Physiol Rev . 1983;;63:844-914.
39 +
Aston-Jones G, Foote SL, Bloom FE.  Anatomy and physiology of locus coeruleus neurons: functional implications.  In: Ziegler MG, Lake CR, eds. Norepinephrine . Baltimore, Md: Williams & Wilkins; 1984;:92-116.
40 +
Aghajanian GK.  Mescaline and LSD facilitate the activation of the locus coeruleus neurons by peripheral stimuli. Brain Res . 1980;;186:492-498.
41 +
Guynet PG, Aghajanian GK.  Acetylcholine, substance P and met-enkephalin in the locus coeruleus: pharmacological evidence for independent sites of action. Eur J Pharmacol . 1979;;53:319-328.
42 +
Calogero AE, Gallucci WT, Chrousos GP, Gold PW.  Interaction between gabaergic neurotransmission and rat hypothalamic corticotropin releasing hormone secretion in vitro. Brain Res . 1988;;463:28-36.
43 +
Kalogeras KT, Calogero AE, Kuribayashi T, et al.  In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic pituitary-adrenal function: pharmacologic and clinical implications. J Clin Endocrinol Metab . 1990;;70:1462-1471.
44 +
Bird SJ, Kuhar MJ.  Iontophoretic application of opiates to the locus ceruleus. Brain Res . 1977;;122:523-533.
45 +
Pepper CM, Henderson G.  Opiates and opioid peptides hyperpolarize locus coeruleus neurons in vitro. Science . 1980;;209:394-396.
46 +
Calogero A, Gallucci WT, Gold PW, Chrousos GP.  Multiple regulatory feedback loops on hypothalamic corticotropin releasing hormone secretion. J Clin Invest . 1988;;82:767-774.
47 +
Yajima F, Suda T, Tomori N, et al.  Effect of opioid peptides on immunoreactive corticotropinreleasing factor release from the rat hypothalamus in vitro. Life Sci . 1986;;39:181-186.
48 +
Plotsky PM.  Opioid inhibition of immunoreactive corticotropin releasing factor secretion into the hypophysial-portal circulation of rats. Regul Pept . 1986;;16:235-242.
49 +
Szemeredi K, Bagdy G, Stull R, Calogero AE, Kopin II, Goldstein DS.  Sympathoadrenomedullary inhibition by chronic glucocorticoid treatment in conscious rats. Endocrinology . 1988;;123:2585-2590.
50 +
Nikolarakis KE, Almeida OFX, Herz A.  Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor. Brain Res . 1986;;399:152-155.
51 +
Burns G, Almeida OFX, Passarelli F, Herz A.  A two step mechanism by which corticotropin releasing hormone releases hypothalamic β-endorphin: the role of vasopressin and G-proteins. Endocrinology . 1989;;125:1365-1372.
52 +
Silverman A, Hou-Yu A, Chen WP.  Corticotropin releasing factor synapses within the paraventricular nucleus of the hypothalamus. Neuroendocrinology . 1989;;49:291-299.
53 +
Aghajanian GK, Cedarbaum MJ, Wang RY.  Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res . 1977;;136:570-577.
54 +
Aghajanian GK, VanderMaelen CP.  α2-Adrenoreceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science . 1982;;215:1394-1396.
55 +
Lamberts SWJ, Verleun T, Oosterom R, deJong F, Hackeny WHL.  Corticotropin releasing factor and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab . 1984;;58:298-303.
56 +
Rittmaster RS, Cutler GB Jr, Brandon D, Gold PW, Loriaux DL, Chrousos GP.  The effects of endogenous vasopressin on ACTH and cortisol secretion in man. J Clin Endocrinol Metab . 1987;;64:371-376.
57 +
Olper HR, Baltzer V.  Vasopressin activates noradrenergic neurons in the rat locus coeruleus: a microiontophoretic investigation. Eur J Pharmacol . 1981;;73:377-378.
58 +
Elkabir DR, Wyatt ME, Vellucci SV, Herbert J.  The effects of separate or combined infusions of corticotropin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. Regul Peptides . 1990;;28:199-214.
59 +
Roth KA, Weber E, Barchas JD, Chang D, Chang JK.  Immunoreactive dynorphin-(1-8) and corticotropin-releasing factor in subpopulation of hypothalamic neurons. Science . 1983;;219:189-191.
60 +
Watson SJ, Akil H, Fischli W, et al.  Dynorphin and vasopressin: common localization in magnocellular neurons. Science . 1982;;216:85-87.
61 +
Millan MH, Millan MJ, Przewlocki R.  Lesions of hypothalamic arcuate nucleus modify discrete brain and pituitary pools of dynorphin in addition to β-endorphin in the rat. Neurosci Lett . 1984;;48:149-154.
62 +
Overton JM, Fisher LA.  Modulation of central nervous system actions of corticotropin-releasing factor by dynorphin-related peptides. Brain Res . 1989;;488:233-240.
63 +
Tassin JP, Lavielle S, Herve D, et al.  Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles. Neuroscience . 1979;;4:1569-1582.
64 +
Roth RH, Tam SY, Lda Y, Yang JS, Deutch AY.  Stress and the mesocorticolimbic dopamine systems. Ann N Y Acad Sci . 1988;;537:138-147.
65 +
Deutch AY, Clark WA, Roth RH.  Prefrontal cortical dopamine depletion enhances the responsiveness of the mesolimbic dopamine neurons to stress. Brain Res . 1990;;521:311-315.
66 +
Deutch AY, Goldstein M, Roth RH.  Activation of the locus ceruleus by selective stimulation of the ventral tegmental area. Brain Res . 1986;;363:307-314.
67 +
Imperato A, Puglisi-Allegra S, Casolini P, Angelucci L.  Changes in brain dopamine and acetycholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res . 1991;;538:111-117.
68 +
Gray TS.  Amygdala: role in autonomic and neuroendocrine responses to stress.  In: McCubbin JA, Kaufman PG, Nemeroff CB, eds. Stress, Neuropeptides and Systemic Disease . New York, NY: Academic Press Inc; 1991;:37-53.
69 +
Gray TS.  Autonomic neuropeptide connections of the amygdala.  In: Tache Y, Morley JE, Brown MR, eds. Neuropeptides and Stress . New York, NY: Springer-Verlag NY Inc; 1989;:92-106.
70 +
Loughlin SE, Foote SL, Grzanna R.  Efferent projections of nucleus locus coeruleus: morphological subpopulations have different efferent targets. Neuroscience . 1986;;18:307-319.
71 +
Stock G, Rupprecht U, Strumpf H, Schlor H.  Cardiovascular changes during arousal elicited by stimulation of amygdala, hypothalamus and locus ceruleus. J Auton Nerv Syst . 1981;;3:503-510.
72 +
Zhang TX, Harper KM, Ni H.  Cryogenic blockade of the central nucleus of the amygdala attenuates aversively conditioned blood pressure and respiratory responses. Brain Res . 1986;;386:136-145.
73 +
Sakanaka M, Shibasaki T, Lederis K.  Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in rat amygdaloid complex. Brain Res . 1986;;382:213-238.
74 +
Wallace DM, Magnuson DJ, Gray TS.  The amygdala-brainstem pathway: selective innervation of dopaminergic, noradrenergic and adrenergic cells in the rat. Neurosci Lett . 1989;;97:252-258.
75 +
Magnuson DJ, Gray TS.  Amygdala directly innervates parvocellular paraventricular hypothalamic CRF, vasopressin and oxytocin containing cells. Soc Neurosci . 1988;;14:1288.
76 +
Smelik PG.  Adaptation and brain function. Prog Brain Res . 1987;;72:3-9.
77 +
McEwen BS, Brinton RE.  Neuroendocrine aspects of adaptation. Prog Brain Res . 1987;;72:11-26.
78 +
Herman JP, Schafer MK-H, Young EA, et al.  Evidence of hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci . 1989;;9:3072-3082.
79 +
Kachaturian H, Lewis ME, Tsou K, Watson SJ.  β-Endorphin, αMSH, ACTH, and related peptides.  In: Bjorkland A, Hokfelt T, eds. Handbook of Chemical Neuroanatomy . Amsterdam, the Netherlands: Elsevier Science Publishers; 1985;;4:216-264.
80 +
Palkovits M, Eskay RL.  Distribution and possible origin of β-endorphin and ACTH in discrete brainstem nuclei of rats. Neuropeptides . 1987;;9:123-137.
81 +
Rabin D, Gold PW, Margioris A, Chrousos GP.  Stress and reproduction: interactions between the stress and reproductive axis.  In: Chrousos GP, Loriaux DL, Gold PW, eds. Mechanisms of Physical and Emotional Stress . New York, NY: Plenum Press; 1988;:377-387.
82 +
Ono N, Lumpkin MD, Samson WK, McDonald JK, McCann SM.  Intrahypothalamic action of corticotropin-releasing factor to inhibit growth hormone and LH release in the rat. Life Sci . 1984;;35:1117-1123.
83 +
Rivier C, Rivier J, Vale W.  Stress-induced inhibition of reproductive function: role of endogenous corticotropin-releasing factor. Science . 1986;;231:607-611.
84 +
MacAdams MR, White RH, Chipps BE.  Reduction in serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med . 1986;;140:648-652.
85 +
Rabin D, Johnson E, Brandon D, Liapi C, Chrousos GP.  Glucocorticoids inhibit estradiol-induced uterine growth: possible role of estrogen receptors. Biol Reprod . 1990;;42:74-80.
86 +
Dieguez C, Page MD, Scanlon MF.  Growth hormone neuroregulation and its alterations in disease states. Clin Endocrinol (Oxf) . 1988;;28:109-143.
87 +
Rivier C, Vale W.  Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology . 1985;;117:2478-2482.
88 +
Unterman TG, Phillips LS.  Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab . 1985;;61:618-626.
89 +
Burguera B, Muruais C, Penalva A, Dieguez C, Casanueva F.  Dual and selective actions of glucocorticoid upon basal and stimulated growth hormone release in man. Neuroendocrinology . 1990;;51:51-58.
90 +
Casanueva FF, Burguera B, Muruais C, Dieguez C.  Acute administration of corticosteroids: a new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab . 1990;;70:234-237.
91 +
Duick DS, Wahner HW.  Thyroid axis in patients with Cushing's syndrome. Arch Intern Med . 1979;;139:767-772.
92 +
Benker G, Raida M, Olbricht T, Wagner R, Reinhardt W, Reinwein D.  TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goitre, and the 'sick euthyroid syndrome.' Clin Endocrinol (Oxf) . 1990;;33:777-786.
93 +
Munck A, Guyre PM.  Glucocorticoid physiology, pharmacology and stress.  In: Chrousos GP, Loriaux DL, Lipsett MB, eds. Steroid Hormone Resistance: Mechanisms and Clinical Aspects . New York, NY: Plenum Press; 1986;:81-96.
94 +
Munck A, Guyre PM, Holbrook NJ.  Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev . 1984;;5:25-44.
95 +
Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W.  Interleukin 1 stimulates the secretion of hypothalamic corticotropin releasing factor. Science . 1987;;238:522-524.
96 +
Naito Y, Fukata J, Tominaga T, et al.  Interleukin 6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely moving rats. Biochem Biophys Res Commun . 1988;;155:1459-1463.
97 +
Bernardini R, Kamilaris TC, Calogero AE, Johnson EO, Gold PW, Chrousos GP.  Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone and adrenocorticotropin secretion in the rat. Endocrinology . 1990;;126:2876-2881.
98 +
Bernardini R, Calogero AE, Ehlich YH, Brucke T, Chrousos GP, Gold PW.  The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology . 1989;;125:1067-1073.
99 +
Bernardini R, Chiarenza A, Calogero AE, Gold PW, Chrousos GP.  Arachidonic acid metabolites modulate rat hypothalamic corticotropin releasing hormone secretion in vitro. Neuroendocrinology . 1989;;50:708-715.
100 +
Gold PW, Loriaux DL, Roy A, et al.  Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: pathophysiologic and diagnostic implications. N Engl J Med . 1986;;314:1329-1335.
101 +
Roy A, Pickar D, Linnoila M, Chrousos GP, Gold PW.  Cerebrospinal fluid corticotropin releasing hormone in depression: relationship to noradrenergic function. Psychiatry Res . 1987;;20:229-237.
102 +
Christiansen NJ, Vestergaard P, Sorenson T, Raphaelson VJ.  Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatr Scand . 1980;;61:178-182.
103 +
Wyatt RJ, Protnoy G, Kupfer DJ, Snyder F, Engelman K.  Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry . 1971;;24:65-70.
104 +
Nemeroff CB, Widerlov E, Poissette G, et al.  Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science . 1984;;226:1342-1344.
105 +
Kling MA, Doran A, Rubinow DR, et al.  CSF levels of CRH, ACTH, and SRIF in Cushing's syndrome, major depression, and normal volunteers: physiological and pathophysiological interrelationships. J Clin Endocrinol Metab . 1991;;72:260-271.
106 +
Gold PW, Gwirtsman H, Avgerinos P, et al.  Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med . 1986;;314:1335-1342.
107 +
Kaye WH, Gwirtsman HE, George DT, et al.  Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocrinol Metab . 1987;;64:203-208.
108 +
Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW.  The CRH stimulation test in patients with panic disorder. Am J Psychiatry . 1986;;143:396-399.
109 +
Gold PW, Pigott TA, Kling MK, Kalogeras K, Chrousos GP.  Basic and clinical studies with corticotropin releasing hormone: implications for a possible role in panic disorder. Psychiatr Clin North Am . 1988;;11:327-334.
110 +
Insel TR, Kalin NH, Guttmacher LB, Cohen RM, Murphy DL.  The dexamethasone suppression test in obsessive-compulsive disorder. Psychiatr Res . 1982;;6:153-160.
111 +
Wand GS, Dobs AS.  Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab . 1991;;72:1290-1295.
112 +
Risher-Flowers D, Adinoff B, Ravitz B, et al.  Circadian rhythms of cortisol during alcohol withdrawal. Adv Alcohol Subst Abuse . 1988;;7:37-41.
113 +
Bardeleben V, Heuser I, Holsboer F.  Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoneuroendocrinology . 1989;;14:441-449.
114 +
Mendelson JH, Teoh SK, Lang V, et al.  Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am J Psychiatry . 1988;;145:1094-1098.
115 +
Mellman TA, Uhde TW.  Withdrawal syndrome with gradual tapering of alprazolam. Am J Psychiatry . 1986;;143:1464-1466.
116 +
Adam K, Oswald I, Shapiro C.  Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol. Psychopharmacology . 1984;;82:389-394.
117 +
Luger A, Deuster P, Kyle SB, et al.  Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise: physiologic adaptations to physical training. N Engl J Med . 1987;;316:1309-1315.
118 +
Malozowski S, Muzzo S, Burrows R, et al.  The hypothalamic-pituitary adrenal axis in infantile malnutrition. Clin Endocrinol . 1990;;32:461-465.
119 +
Kamilaris A, Calogero AE, Johnson EO, Gold PW, Chrousos GP.  Effects of hypothyroidism and hyperthyroidism on the basal activity of the hypothalamic-pituitary-adrenal axis. Clin Res . 1989;;37:360A.
120 +
Rabin D, Schmidt P, Gold PW, Rubinow D, Chrousos GP.  Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. J Clin Endocrinol Metab . 1990;;71:1158-1162.
121 +
Cantwell DP, Sturzenberger S, Burroughs J, Salkin B, Green JK.  Anorexia nervosa: an affective disorder? Arch Gen Psychiatry . 1977;;34:1087-1093.
122 +
Winokur A, March W, Mendels J.  Primary affective disorder in relatives of patients with anorexia nervosa. Am J Psychiatry . 1980;;137:695-698.
123 +
Gold PW, Ballenger JC, Robertson GL, et al.  Vasopressin in affective illness: direct measurement, clinical trials, and response to hypertonic saline.  In: Post RM, Ballenger JC, eds. Neurobiology of Mood Disorders . Baltimore, Md: Williams & Wilkins; 1984;:323-339.
124 +
DeWied D.  The importance of vasopressin in memory. Trends Neurosci . 1984;;7:62-63.
125 +
Yates A, Leehey K, Shisslak CM.  Running—an analogue of anorexia? N Engl J Med . 1983;;308:251-255.
126 +
MacConnie SE, Barkan A, Lampman RM, Schork MA, Beitins IZ.  Decreased hypothalamic gonadotropin-releasing hormone secretion in male marathon runners. N Engl J Med . 1986;;315:411-417.
127 +
Villanueva AL, Schlosser C, Hopper B, Liu JH, Hoffman DI, Rebar RW.  Increased cortisol production in women runners. J Clin Endocrinol Metab . 1986;;63:133-136.
128 +
Piazza PV, Maccari S, Deminiere JM, Le Moal M, Mormede P, Simon H.  Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci U S A . 1991;;88:2088-2092.
129 +
Vanderpool J, Rosenthal N, Chrousos GP, Wher T, Gold PW.  Evidence for hypothalamic CRH deficiency in patients with seasonal affective disorder. J Clin Endocrinol Metab . 1991;;72:1382-1387.
130 +
Demitrack MA, Dale JK, Straus S, et al.  Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab . 1991;;73:1224-1234.
131 +
Kamilaris TC, DeBold RC, Pavlou SN, Island DP, Hoursanidis A, Orth DN.  Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab . 1987;;65:994-999.
132 +
Kopelman PG, Grossman A, Lavender P, Besser GM, Rees LH, Coy D.  The cortisol response to corticotrophin-releasing factor is blunted in obesity. Clin Endocrinol (Oxf) . 1988;;28:15-18.
133 +
Bernasconi S, Petraglia F, Iughetti L, et al.  Impaired β-endorphin response to human corticotropin-releasing hormone in obese children. Acta Endocrinol. (Copenh) . 1988;;119:7-10.
134 +
Bernini GP, Argenio GF, Viraldi MJ, et al.  Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotonergic system. Horm Res . 1989;;31:133-137.
135 +
Mason JW, Giller EL, Kosten TR, Ostroff RB, Podd L.  Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis . 1986;;174:145-149.
136 +
Yehuda R, Southwick SM, Nussbaum F, Wahby V, Giller EL, Mason JW.  Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis . 1990;;178:366-369.
137 +
McFall ME, Murburg MM, Ko GN, Veith RC.  Autonomic responses to stress in Vietnam combat veterans with posttraumatic stress disorder. Biol Psychiatry . 1990;;27:1165-1175.
138 +
Butler RW, Braff DL, Rausch TL, Jenkins MA, Sprock J, Geyer MA.  Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry . 1990;;147:1308-1312.
139 +
Elgerot A.  Psychological and physiological changes during tobacco-abstinence in habitual smokers. J Clin Psychol . 1978;;34:759-764.
140 +
West RJ, Russell MAH, Jarvis MJ, Pizzey T, Kadam B.  Urinary adrenaline concentrations during 10 days of smoking abstinence. Psychopharmacology . 1984;;84:141-142.
141 +
Puddey JB, Vandongen R, Beilin LJ, English D.  Haemodynamic and neuroendocrine consequences of stopping smoking—a controlled study. Clin Exp Pharmacol Physiol . 1984;;11:423-426.
142 +
Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T.  Smoking cessation and severity of weight gain in a national cohort. N Engl J Med . 1991;;324:739-745.
143 +
Sternberg E, Hill JM, Chrousos GP, et al.  Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A . 1989;;86:2374-2378.
144 +
Sternberg EM, Young WS Jr, Bernardini R, et al.  A central nervous defect in the stress response is associated with susceptiblility to streptococcal cell wall arthritis in Lewis rats. Proc Natl Acad Sci U S A . 1989;;86:4771-4775.
145 +
Sternberg EM, Glowa J, Smith M, et al.  Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res . 1992;;570:54-60.
146 +
Gawin GH.  Cocaine addiction: psychology and neurophysiology. Science . 1991;;251:1580-1586.
147 +
Thoman EB, Levine ES, Arnold WJ.  Effects of maternal deprivation and incubation rearing on adrenocortical activity in the adult rat. Dev Psychobiol . 1968;;1:21-23.
148 +
Kagan J, Reznick JS, Snidman N.  Biological bases of childhood shyness. Science . 1988;;240:167-171.
149 +
Kagan J, Reznick JS, Snidman N.  Temperamental influences on reactions to unfamiliarity and challenge.  In: Chrousos GP, Loriaux DL, Gold PW, eds. Mechanisms of Physical and Emotional Stress . New York, NY: Plenum Press; 1988;:319-339.
150 +
Werner EE.  Children of the garden island. Sci Am . (April) 1989;;260:106-111.
151 +
Bouchard TJ Jr, Lykken DT, McGue M, Segal NL, Tellegen A.  Sources of human psychological differences: The Minnesota Study of Twins Reared Apart. Science . 1990;;250:223-250.

Letters

Submit a Letter
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems